Patients with advanced ovarian cancer have a very high relapse rate following primary treatment, with 60 to 85% of patients relapsing. Treatment planning is an important factor in patient care, but few reliable options exist to help physicians accurately plan treatment and select patients who are appropriate candidates for a specific therapy.
Rese (Read more...)